Refex Industries share price gains after Refex Green Mobility Limited (“Refex eVeelz”), a wholly owned subsidiary of Refex Industries Limited, has agreed with one of India’s largest ride-hailing platforms to induct and operate 1,000 electric four-wheelers (e4Ws) across Chennai, Hyderabad, Bengaluru, and Mumbai in FY26.

Strengthening India’s Clean Mobility Transition

This strategic expansion is part of Refex eVeelz’s long-term growth roadmap, reinforcing its commitment to advancing India’s clean mobility transition. With a 100% electric fleet, the initiative aims to drive large-scale electric vehicle (EV) adoption while minimizing urban carbon footprints through the reduction of tailpipe emissions.

The ride-hailing platform will continue catering to demand and building new mobility categories, while Refex eVeelz will focus on service delivery, ensuring reliable and sustainable transportation solutions across key metropolitan cities.

Management Outlook

Speaking on the development, Anil Jain, Managing Director of Refex Industries Limited, said, “At Refex eVeelz, we are committed to playing a leading role in shaping the future of sustainable mobility in India. This strategic expansion not only strengthens our presence across key metropolitan cities but also aligns with our long-term vision of enabling a cleaner, smarter, and more efficient transportation ecosystem.”

Scaling Up EV Fleet Operations

Refex eVeelz is already a leader in four-wheeler EV-as-a-service, currently operating a fleet of nearly 1,300 electric vehicles across multiple cities, including Chennai, Bengaluru, Hyderabad, Mumbai, and Pune.

The addition of 1,000 new e4Ws, along with the organic growth of its fleet in the employee transportation segment, will further cement its role in mainstreaming electric mobility solutions in India.

This initiative aligns with India’s broader sustainability vision, contributing to the nation’s net-zero emissions target by 2070.

Stock Performance

On March 05, 2025, Refex Industries share price traded 4.26% higher at ₹397.95 at 9:58 AM (IST). Refex Industries’s share price reached a 52-week high of ₹600, and a 52-week low of ₹120.32. As per BSE, the total traded volume for the stock stood at 6,815 shares with a turnover of ₹26.80 lakhs.

At the current price, Refex Industries shares are trading at a price-to-earnings (P/E) ratio of 30.52x, based on its trailing 12-month earnings per share (EPS) of 13.04, and a price-to-book (P/B) ratio of 8.11, according to exchange data.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Coforge, a mid-tier IT services company, has announced a strategic $1.56 billion deal with Sabre, a leading US-based travel technology firm. The agreement aims to accelerate product delivery and introduce advanced artificial intelligence (AI)-enabled solutions for Sabre’s global operations.

The 13-year engagement is the largest contract in Coforge’s history and is expected to generate approximately $120 million in annual revenue for the company.

Strengthening Long-Term Partnership

Commenting on the landmark deal, Sudhir Singh, Chief Executive Officer and Executive Director of Coforge, said, “Our new agreement is a major milestone in our partnership with Sabre. The scale and complexity of the mandate reflect the deep trust and capability that both organisations bring to this partnership. It underlines, once again, our strong commitment to engineering excellence and driving emerging innovation and transformation for our clients.”

The deal is especially significant as major IT services firms have observed a trend of smaller contracts with shorter timelines from clients. This agreement, however, reinforces Coforge’s position as a key player in the digital transformation of the travel technology sector.

Sabre’s Perspective on the Collaboration

Sabre’s Chief Executive Officer and President, Kurt Ekert, highlighted the importance of this partnership in advancing technological innovations. “Sabre is in an advantaged position to pioneer, build, and deploy the next generation of solutions alongside our continuously expanding travel marketplace, and we look forward to Coforge’s partnership in expediting the process,” he stated.

Driving AI-Led Innovation in Travel Technology

Through this long-term agreement, Coforge will focus on leveraging AI to enhance Sabre’s product offerings, streamline operations, and improve the overall customer experience. The deal is expected to boost Sabre’s ability to remain competitive in the fast-evolving travel technology landscape.

Stock Performance 

On March 05, 2025, Coforge share price traded 8.77% higher at ₹7,835.65 at 9:40 AM (IST). Coforge’s share price reached a 52-week high of ₹10,017.95 on December 30, 2024, and a 52-week low of ₹4,291.05 on May 09, 2024. As per BSE, the total traded volume for the stock stood at 0.30 lakh shares with a turnover of ₹23.22 crores.

At the current price, Coforge shares are trading at a price-to-earnings (P/E) ratio of 73.82x, based on its trailing 12-month earnings per share (EPS) of 106.30, and a price-to-book (P/B) ratio of 9.38, according to exchange data.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Apollo Hospitals Enterprise Ltd announced on Tuesday, March 4, its plans to set up a state-of-the-art oncology centre featuring India’s first Proteus One proton system. The company will invest ₹250 crore over the next three years to establish the facility in Hyderabad, which is expected to be operational by FY2028.

Expansion of Proton Therapy Capacity

The new facility aims to enhance Apollo’s existing proton therapy capacity, which currently treats over 500 patients annually at its Chennai centre, designed for 850 patients. With the Hyderabad expansion, Apollo will be able to treat an additional 350 patients every year. The investment for this initiative will be funded through internal accruals.

Collaboration with Ion Beam Applications (IBA)

Apollo Hospitals has partnered with Ion Beam Applications (IBA), a global leader in proton beam therapy solutions, to introduce the Proteus One system in India. Apollo first pioneered proton therapy in 2019 at its Chennai centre, making it the only such facility in South Asia and the Middle East.

Benefits of Proton Therapy for Cancer Treatment

Proton therapy is a highly advanced form of radiation treatment, primarily used for complex cancers, including central nervous system, head and neck tumours, paediatric, and urological cancers. The Proteus One system will offer cutting-edge precision, ensuring superior clinical outcomes and minimizing side effects for patients.

Leadership’s Vision for the Project

Dr Prathap C Reddy, Founder-Chairman of Apollo Hospitals Enterprise Ltd, emphasized the significance of this development, stating, “The addition of Proteus One to our Apollo Proton Cancer Centres further solidifies our position as a global leader in proton therapy. This next-generation technology will allow us to achieve superior clinical outcomes and significantly improve the quality of life for cancer patients in India and beyond.”

Stock Performance

On March 05, 2025, Apollo Hospitals share price traded 0.69% lower at ₹6149.05 at 9:19 AM (IST). Apollo Hospitals’s share price reached a 52-week high of ₹7,545.10 on November 18, 2024, and a 52-week low of ₹5,690.80 on June 04, 2024. As per BSE, the total traded volume for the stock stood at 147 shares with a turnover of ₹9.10 lakhs.

At the current price, Apollo Hospitals shares are trading at a price-to-earnings (P/E) ratio of 73.81x, based on its trailing 12-month earnings per share (EPS) of ₹83.58, and a price-to-book (P/B) ratio of 10.83, according to exchange data.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

 

Samvardhana Motherson International (Motherson) has been selected as a Tier 1 supplier of Airbus commercial aircraft. The agreement, signed through its subsidiary CIM Tools India Pvt. Ltd., entails the supply of aerospace components and assemblies directly to Airbus’ final assembly lines.

Production from the Bengaluru Facility

Under this contract, production and deliveries will be carried out from Motherson’s aerospace facility in Bengaluru. The company already holds the status of a Tier 1 supplier for Airbus Helicopter and Airbus Defence and Space, and this latest contract further strengthens its long-standing partnership with the European aircraft manufacturer.

Leadership’s Perspective on the Milestone

Expressing pride in the achievement, Motherson Chairman Vivek Chaand Sehgal stated, “We are proud to be recognised as a Tier 1 supplier to Airbus commercial aircraft. This achievement highlights our manufacturing capabilities, high-quality standards, and commitment to timely delivery.”

Kunal Bajaj, President of Motherson’s Aerospace Business Division, highlighted the business growth potential of this deal, stating that the company’s investments in advanced manufacturing technologies and quality systems have significantly strengthened its position in the aerospace supply chain.

Motherson’s Expanding Aerospace Capabilities

Motherson’s aerospace division operates 16 facilities across four countries, supplying critical components for all sections of an aircraft, from nose to tail. This new contract with Airbus marks another key milestone in the company’s aerospace expansion and reaffirms its commitment to delivering world-class solutions to the aviation industry.

Stock Performance 

On March 04, 2025, Samvardhana Motherson share price ended 0.92% lower at ₹118.30. Samvardhana Motherson’s share price reached a 52-week high of ₹217.00 on September 27, 2024, and a 52-week low of ₹107.05 on March 14, 2024. As per BSE, the total traded volume for the stock stood at 3.18 lakh shares with a turnover of ₹3.77 crores.

At the current price, Samvardhana Motherson shares are trading at a price-to-earnings (P/E) ratio of 62.93x, based on its trailing 12-month earnings per share (EPS) of ₹1.88, and a price-to-book (P/B) ratio of 2.25, according to exchange data.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Business services provider Quess Corp announced on Tuesday, March 4, that the National Company Law Tribunal (NCLT), Bengaluru Bench, has approved its corporate restructuring exercise.

In a regulatory filing, the company stated, “…the National Company Law Tribunal, Bengaluru Bench (NCLT) has today, March 4, 2025, pronounced the order approving and sanctioning the Composite Scheme of Arrangement between Quess Corp Limited, Digitide Solutions Limited (Digitide), and Bluspring Enterprises Limited (Bluspring) and their respective shareholders and creditors (Scheme).”

The restructuring will become effective once the certified copy of the NCLT order is filed with the Registrar of Companies, Bengaluru, Karnataka. Quess Corp had previously provided updates on the proceedings on December 23, 2024, and January 7, 2025.

Demerger Plan and Business Focus

Last year, Quess Corp announced a demerger plan aimed at splitting its business into three independent, publicly listed entities:

• Quess Corp (existing listed entity) will focus on workforce management.
• Digitide Solutions will specialize in insurtech and human resource outsourcing (HRO).
• Bluspring Enterprises will focus on facility management and industrial services.

As part of this restructuring, shareholders of Quess Corp will receive one share of each of the two newly demerged companies for every share they own in the currently listed entity.

Strategic Rationale Behind the Demerger

Quess Corp has emphasized that the demerger is aimed at creating focused, independent businesses that can scale efficiently. The company highlighted the benefits of this restructuring, which include:

• Pure-Play Vertical Focus

Each entity will have a dedicated focus on its respective industry, improving specialization and business positioning.

• Simplified Corporate Structure

The restructuring will result in independent, scaled platforms for each business vertical, ensuring better operational efficiency.

• Optimal Capital Allocation Strategy

Each company will have a clearer capital allocation plan to drive growth and maximise shareholder value.

Stock Performance 

On March 04, 2025, Quess Corp share price ended 0.74% higher at ₹587.60. Quess Corp’s share price reached a 52-week high of ₹875.00 on September 23, 2024, and a 52-week low of ₹464.40 on March 13, 2024. As per BSE, the total traded volume for the stock stood at 3941 shares with a turnover of ₹23.02 lakhs

At the current price, Quess Corp shares are trading at a price-to-earnings (P/E) ratio of 23.02x, based on its trailing 12-month earnings per share (EPS) of ₹29.64, and a price-to-book (P/B) ratio of 3.08, according to exchange data.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Technology services provider Coforge has announced its decision to implement a stock split, following approval from its board.

Coforge Stock Split Details

As per the proposal, one equity share with a face value of ₹10 will be split into five equity shares, each carrying a face value of ₹2. This marks the first-ever stock split undertaken by the company.

The stock split remains subject to shareholder approval, and the record date for the same will be communicated in due course, the company stated in its exchange filing. The entire process, including the credit of new shares into shareholders’ demat accounts, is expected to be completed over the next three months.

Increase in Outstanding Shares

Following the stock split, the total number of outstanding shares of Coforge will increase from 6.68 crore to 33.43 crore. The move is aimed at enhancing liquidity and making the stock more accessible to retail investors.

How Much Extra Shares Will Investors Get?

Currently, Coforge shares trade at ₹7,215. If the stock remains at this price on the record date of the split, the adjusted price post-split will be ₹1,443 per share.

An investor holding 100 shares before the split will have 500 shares after the split at the new adjusted price. However, the actual share price on the record date may vary.

Stock Performance 

On March 04, 2025, Coforge share price ended 2.07% lower at ₹7,204.10. Coforge’s share price reached a 52-week high of ₹10,017.95 on December 30, 2024, and a 52-week low of ₹4,291.05 on May 09, 2024. As per BSE, the total traded volume for the stock stood at 6,802 shares with a turnover of ₹4.93 crore.

At the current price, Coforge shares are trading at a price-to-earnings (P/E) ratio of 67.77x, based on its trailing 12-month earnings per share (EPS) of ₹106.30, and a price-to-book (P/B) ratio of 8.61, according to exchange data.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Indian markets are expected to be impacted today. As of 7:38 AM, GIFT Nifty futures were down by 60.55 points at 22,130.50.

In the previous session, the Sensex dropped by 96.01 points (0.13%) to 72,989.93, while the Nifty50 fell by 36.65 points (0.17%) to 22,082.65.

Here are the key stocks to watch today on March 05, 2025:

Coforge

Technology services provider Coforge has announced its first-ever stock split, with the company’s board approving the decision in the early hours of Wednesday, March 5. Under the approved proposal, each equity share with a face value of ₹10 will be subdivided into five shares, each carrying a revised face value of ₹2.

Biocon

Biotechnology major Biocon has obtained final approval from the US Food and Drug Administration (USFDA) for its Lenalidomide capsules in multiple strengths. The drug is used in the treatment of multiple myeloma, lymphoma, and myelodysplastic syndromes.

Adani Wilmar

FMCG major Adani Wilmar has signed a definitive agreement to acquire GD Foods Manufacturing, the company behind the Tops brand. The acquisition will be executed in phases, with Adani Wilmar acquiring an 80% stake initially, while the remaining 20% will be acquired over the next three years.

Jio Financial

Jio Financial Services will acquire the 17.83% stake in Jio Payments Bank from the State Bank of India for ₹104.54 crore. Following the transaction, Jio Payments Bank will become a wholly owned subsidiary of Jio Financial Services. The acquisition is subject to approval from the Reserve Bank of India and is expected to be finalized within 45 days after clearance.

Ola Electric 

Electric vehicle manufacturer Ola Electric has been issued a notice by IFCI Ltd for failing to meet its first milestone under the Production Linked Incentive (PLI) Advanced Chemistry Cell scheme. The company acknowledged that it had not achieved the targets set under the agreement signed in July 2022.

Apollo Hospitals

Apollo Hospitals is set to expand its proton therapy capacity with a ₹250 crore investment in a comprehensive oncology centre in Hyderabad. The facility will house India’s first Proteus One proton system and is expected to become operational by FY2028.

Power Grid Corp

State-run Power Grid Corporation has secured three inter-state transmission system projects under the tariff-based competitive bidding model. The projects will be developed under the Build, Own, Operate, and Transfer (BOOT) model. The company received the Letter of Intent (LoI) on March 3, 2025, solidifying its role in strengthening the country’s power transmission infrastructure.

Grasim

Aditya Birla Group’s Grasim Industries has begun commercial production at its Birla Opus Paints plant in Mahad, Maharashtra. The facility boasts a total installed capacity of 230 million litres per annum, manufacturing a range of water-based, solvent-based, and distemper paints.

Walchandnagar

Pune-based Walchandnagar Industries is set to acquire a 60.3% stake in Aicitta Intelligent Technology, a startup specialising in unmanned defense systems. The Rs 16 crore investment will be made through a combination of equity shares and compulsorily convertible preference shares, strengthening Walchandnagar’s presence in the defense sector.

GE Vernova T&D

GE Vernova T&D India has secured orders worth ₹500 crore from Power Grid Corporation of India Ltd for the supply and installation of 765kV class transformers and reactors. The orders were awarded under bulk procurement, further strengthening GE Vernova’s role in India’s power transmission sector.

Ambuja Cement

The Competition Commission of India (CCI) has approved Ambuja Cements’ proposal to acquire a 72.8% stake in Orient Cement. Announcing the decision on social media platform X, CCI stated, “CCI approves the proposed acquisition of up to 72.8% shareholding of Orient Cement Limited by Ambuja Cements Limited.”

Conclusion

Indian markets are set for a cautious start, influenced by GIFT Nifty trends. Key corporate developments, including Coforge’s stock split, Biocon’s USFDA approval, Adani Wilmar’s acquisition, and Jio Financial’s stake buy, highlight dynamic sectoral movements. Major investments and regulatory clearances further shape the evolving business landscape on March 5, 2025.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

On March 4, 2025, the Indian benchmark indices ended lower, whereby Nifty 50 fell 0.17% to 22,082.65 while Sensex dropped 0.13% to 72,989.93.

Top Gainers of the Day

SBIN 

State Bank Of India (SBI) climbed 3.03%, reaching ₹716.4, supported by its consistent performance and strong market presence.

BPCL

BPCL rose 2.97%, closing at ₹249.6, bolstered by improved investor outlook and favourable market conditions.

BEL

BEL climbed 2.80%, reaching ₹264.6, supported by its consistent performance and strong market presence.

Shriram Finance

Shriram Finance gained 2.03%, peaking at ₹633.9, reflecting robust growth in the NBFC sector.

Adani Enterprises

Adani Enterprise rose 1.44%, closing at ₹2,147.6, bolstered by improved investor outlook and favourable market conditions.

Top Losers of the Day

Bajaj Auto

Bajaj Auto fell 4.95%, dropping to ₹7,332.95, following concerns over sector performance.

Hero MotoCorp

Hero MotoCorp saw a decline of 3.34%, with its price dipping to ₹3,509.6, influenced by traffic features and Tesla entry.

Bajaj Finserv 

Bajaj Finserv declined 2.65%, ending at ₹1,789.9, following concerns over sector performance.

HCL Technologies

Bajaj Finserv declined 2.28%, ending at ₹1,536.5, following concerns over sector performance.

Eicher Motors

Eicher Motors slipped 2.01%, closing at ₹4,808.05, following concerns over sector performance.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

On March 04, 2025, HDFC Bank share price traded 0.04% lower at ₹1700.50 at 11:53 AM (IST). HDFC Bank’s share price reached a 52-week high of ₹1,880 on December 09, 2024, and a 52-week low of ₹1,421.05 on March 27, 2024. As per BSE, the total traded volume for the stock stood at 0.53 lakh shares with a turnover of ₹9.04 crore.

At the current price, HDFC Bank shares are trading at a price-to-earnings (P/E) ratio of 19.63x, based on its trailing 12-month earnings per share (EPS) of ₹86.61, and a price-to-book (P/B) ratio of 2.83, according to exchange data.

Shareholding Details

As of December 31, 2024, HDFC Bank Foreign Institutional Investors (FIIs) owned 49.21%, Domestic Institutional Investors (DIIs) held 34.37%, and the Public (Retail Investors) held 16.23%.

HDFC Bank Q3 FY25 Results

India’s largest private sector lender, HDFC Bank, announced its financial results for the third quarter of FY25, reporting a 2.2% year-on-year (YoY) increase in standalone net profit to ₹16,736 crore.

Stable Net Interest Income Amid NPA Concerns

The bank’s Net Interest Income (NII), a key profitability metric, grew 8% YoY to ₹30,690 crore, aligning with market expectations. However, the Net Interest Margin (NIM) remained flat at 3.4% for the quarter.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

On March 04, 2025, Jio Financial share price traded 2.56% higher at ₹206.10 at 11:13 AM (IST). Jio Financial’s share price reached a 52-week high of ₹394.70 on April 23, 2025, and a 52-week low of ₹198.60 on March 03, 2025. As per BSE, the total traded volume for the stock stood at 16.69 lakh shares with a turnover of ₹33.94 crore.

At the current price, Jio Financial shares are trading at a price-to-earnings (P/E) ratio of 241.09x, based on its trailing 12-month earnings per share (EPS) of ₹0.83, and a price-to-book (P/B) ratio of 5.14, according to exchange data.

Shareholding Details

As of December 31, 2024, Jio Financial promoters held 47.12% of the shares, Foreign Institutional Investors (FIIs) owned 15.62%, and Domestic Institutional Investors (DIIs) held 12.46%.

Jio Financial Q3 FY25 Results

Jio Financial Services Ltd (JFSL), the financial arm of Mukesh Ambani-led Reliance Industries Ltd (RIL), reported a marginal 0.3% increase in net profit for the third quarter ended December 31, 2024.

The company’s net profit stood at ₹294.8 crore, slightly up from ₹293.8 crore in the same period last year.

Revenue Growth and Market Performance

JFSL’s revenue from operations grew by 6% year-on-year, reaching ₹438.4 crore, compared to ₹413.6 crore in Q3 FY24.

The company announced its financial results after the market closed, with its stock closing at ₹279.05 on the BSE, up ₹2.30 or 0.83%.

Strong Asset Growth and CASA Expansion

The company’s assets under management (AUM) witnessed significant growth, surging to ₹4,199 crore in Q3 FY25 from ₹1,206 crore in Q2 FY25. Additionally, Jio Financial Services’ payments bank segment recorded a 25% quarter-on-quarter increase in its Current Account and Savings Account (CASA) customer base, reaching 1.89 million.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.